Back
NovoCure Ltd. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
NVCR
NovoCure Ltd.
Last Price:
$13.29
Seasonality Move:
-11.88%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and NVCR is experiencing selling pressure, which indicates risk of future bearish movement.
NovoCure Ltd. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.08 | Buy |
| 20-day SMA: | 12.69 | Buy |
| 50-day SMA: | 12.55 | Buy |
| 200-day SMA: | 14.8 | Sell |
| 8-day EMA: | 13.19 | Buy |
| 20-day EMA: | 12.87 | Buy |
| 50-day EMA: | 12.72 | Buy |
| 200-day EMA: | 14.81 | Sell |
NovoCure Ltd. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 56.21 | Buy |
| Chaikin Money Flow: | -528545 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.98 - 13.34) | Buy |
| Bollinger Bands (100): | (11.66 - 13.54) | Buy |
NovoCure Ltd. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NovoCure Ltd. Stock
Is NovoCure Ltd. Stock a Buy?
-
NovoCure Ltd. share price is 13.27 while NVCR 8-day simple moving average is 13.08, which is a Buy signal.
-
The stock price of NVCR is 13.27 while NovoCure Ltd. 20-day SMA is 12.69, which makes it a Buy.
-
NovoCure Ltd. 50-day simple moving average is 12.55 while NVCR share price is 13.27, making it a Buy technically.
-
NVCR stock price is 13.27 and NovoCure Ltd. 200-day simple moving average is 14.80, creating a Sell signal.
NVCR Technical Analysis vs Fundamental Analysis
Sell
47
NovoCure Ltd. (NVCR)
is a Sell
Is NovoCure Ltd. a Buy or a Sell?
-
NovoCure Ltd. stock is rated a SellThe current NovoCure Ltd. [NVCR] share price is $13.27. The Score for NVCR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
NovoCure Ltd. Stock Info
Market Cap:
1.5B
Price in USD:
13.27
Share Volume:
775.2K
NovoCure Ltd. 52-Week Range
52-Week High:
31.17
52-Week Low:
10.70
Sell
47
NovoCure Ltd. (NVCR)
is a Sell
NovoCure Ltd. Share Price Forecast
-
What is the NovoCure Ltd. stock price today?The NovoCure Ltd. stock price is 13.27 USD today.
-
Will NVCR stock go up or go down?NovoCure Ltd.> share price is forecast to RISE/FALL based on technical indicators
-
Is NovoCure Ltd. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovoCure Ltd. is overvalued.
Is NovoCure Ltd. Stock a Buy?
-
NovoCure Ltd. share price is 13.27 while NVCR 8-day exponential moving average is 13.19, which is a Buy signal.
-
The stock price of NVCR is 13.27 while NovoCure Ltd. 20-day EMA is 12.87, which makes it a Buy.
-
NovoCure Ltd. 50-day exponential moving average is 12.72 while NVCR share price is 13.27, making it a Buy technically.
-
NVCR stock price is 13.27 and NovoCure Ltd. 200-day simple moving average is 14.81, creating a Sell signal.
Fundamental Analysis of NovoCure Ltd.
Is NovoCure Ltd. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and a decrease next year of $0.10 per share.
Technical Analysis of NovoCure Ltd.
Should I short NovoCure Ltd. stock?
-
NVCR Moving Average Covergence Divergence (MACD) indicator is 0.28, suggesting NovoCure Ltd. is a Buy
-
NovoCure Ltd. Relative Strength Index (RSI) is 56.21, which suggest NovoCure Ltd. is overbought
-
The Bollinger Bands (25) for NovoCure Ltd. is (11.98 - 13.34), which suggest NovoCure Ltd. is a Buy
-
The Bollinger Bands (100) for NovoCure Ltd. is (11.66 - 13.54), which suggest NovoCure Ltd. is a Buy
* NovoCure Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.